Live Breaking News & Updates on Launch Diagnostics

Stay updated with breaking news from Launch diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Avacta : Results for the Year Ended 31 December 2023

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS NO. 596/2014 AS IT FORMS. ....

United Kingdom , United States , San Diego , Shaun Chilton , Coris Bioconcept , Adcs Affdcs , Michael Vinegrad , Eli Lilly , Eliot Forster , Alastair Smith , Tony Gardiner , Christina Coughlin , Patrick Birkholm , Avacta Affimer , Nick Harland Ben , Diagnostics Division , Avacta Diagnostics Division , Stifel Nicolaus Europe Limited Nomad , American Association For Cancer Research , Avacta Therapeutics Division , Whilst The Diagnostics Division , Head Of Research Development , Avacta Group , Lg Chem Life Sciences , International Conference On Molecular , Head Of Research ,

Avacta : Preliminary Results for the Year Ended 31 December 2023

Avacta appoints new Chief Executive Officer Christina Coughlin, MD PhD

Clinical proof-of-concept demonstrated for Avacta s lead programme AVA6000 and proof-of-mechanism for the. ....

San Diego , United States , United Kingdom , Shaun Chilton , Coris Bioconcept , Eliot Forster , Christina Coughlin , Alastair Smith , Avacta Group , Head Of Research Development , Diagnostics Division , Avacta Diagnostics Division , Therapeutics Division , American Association For Cancer Research , Chief Executive Officer Christina Coughlin , American Association , Cancer Research , Fibroblast Activation Protein , Xell Therapeutics , Daewoong Pharmaceutical , Chief Business Officer , Chief Executive Officer , Non Executive Director , Clinical Proof , Belgium Based Coris Bioconcept , Launch Diagnostics ,

Avacta : acquires Coris Bioconcept, adding a broad range of marketed professional-use rapid tests to the Group

Acquisition consistent with Avacta Diagnostics M&A strategy and complements earlier acquisition of Launch Diagnostics

Avacta Group plc , a life sciences company developing. | June 1, 2023 ....

United States , Waals Gewest , United Kingdom , Alastair Smith , Coris Bioconcept , Avacta Group , Launch Diagnostics , South America , Middle East , Quality Control , Avacta Diagnostics , Chief Executive Officer , Avacta Group Plc Stock Exchange , Press Release , Ompany Avct Gb00byyw9g87 ,

Avacta acquires rapid diagnostic test firm Coris Bioconcept

Avacta Group has acquired Coris Bioconcept, a European manufacturer of rapid diagnostic test kits. ....

Waals Gewest , United States , Alastair Smith , South America , Launch Diagnostics , Markets Amp Regulations , Covid 19 ,

Acquisition expands life sciences company's medical tests portfolio

The acquired business manufactures rapid diagnostic test kits for use by healthcare professionals ....

Waals Gewest , Alastair Smith , Coris Bioconcept , Avacta Group , Launch Diagnostics , Avacta Diagnostics , Wetherby Based Avacta Group , South West ,